WASHINGTON, D.C. -- -- The Department of Health & Human
Services would conduct "oversight and supervision" of Group Purchasing
Organizations (GPOs) under the provisions of new bipartisan legislation
offered by Senators Herb Kohl (D-Wis.) and Mike DeWine (R-Ohio). The Medical
Device Manufacturers Association (MDMA) hailed the bill as "a critical step"
in addressing the anticompetitive and other questionable practices by certain
GPOs that have long prevented cost-effective medical technologies from
reaching the market.
GPOs operate under a legal "safe harbor" exemption from the anti-kickback
provisions of the Social Security Act. The Kohl/DeWine bill would authorize
HHS, in consultation with the Federal Trade Commission, to ensure that GPOs do
not use the safe harbor to "shield conduct that harms competition in the
hospital supply and medical device industries."
MDMA Executive Director Mark Leahey said the impetus for the legislation
is the fact that "some GPOs have not adequately addressed the anticompetitive
contracting practices that have denied patients access to cost-effective
technologies." Three hearings by the Senate Antitrust Subcommittee and a
series of investigative reports in The New York Times revealed that despite
some improvements, it had become obvious that certain GPOs would not reform
their behavior without federal intervention.
The MDMA has long asserted that the contracting practices of certain GPOs were
effectively locking innovative products out of the hospital marketplace.
Leahey said: "We are grateful to Senators DeWine and Kohl for their
persistence and leadership in ensuring that competition is allowed to flourish
in the hospital supply industry. This legislation will allow healthcare
professionals and the patients they serve to gain access to a wide array of
innovative medical technologies that can save lives."
The Medical Device Manufacturers Association (MDMA) seeks to improve the
quality of patient care by encouraging the development of new medical
technology and fostering the availability of innovative products in the
marketplace. A national trade association based in Washington, D.C., MDMA
represents thousands of innovators and entrepreneurs in the medical device
community, including over 200 dues-paying members who develop and manufacture
medical devices, diagnostic products, and health care information systems.
Source: Medical Device Manufacturers Association
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.